CVE:COV - Covalon Technologies Stock Price, News, & Analysis

C$4.15
0.00 (0.00 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
C$4.15
Now: C$4.15
C$4.15
50-Day Range
C$4.01
MA: C$4.46
C$5.13
52-Week Range
C$3.54
Now: C$4.15
C$9.45
Volume200 shs
Average Volume7,789 shs
Market CapitalizationC$92.29 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Covalon Technologies Ltd., an advanced medical technologies company, researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has three proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products that treat chronic and infected wounds, such as diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform, which is used in a family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone; and medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. It sells wound care dressing, surgical and peri-operative, and infection management products under the Covalon brand name. The company also offers development contracts, licensing agreements, and distribution contracts services. It provides its technologies, products, and services to various health care providers, such as hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-905-5688400

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$35.17 million
Cash FlowC$0.08 per share
Book ValueC$0.60 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$92.29 million
Next Earnings Date8/27/2019 (Estimated)
OptionableNot Optionable

Receive COV News and Ratings via Email

Sign-up to receive the latest news and ratings for COV and its competitors with MarketBeat's FREE daily newsletter.

Covalon Technologies (CVE:COV) Frequently Asked Questions

What is Covalon Technologies' stock symbol?

Covalon Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "COV."

How were Covalon Technologies' earnings last quarter?

Covalon Technologies Ltd (CVE:COV) announced its quarterly earnings data on Tuesday, May, 28th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $13.31 million for the quarter. View Covalon Technologies' Earnings History.

When is Covalon Technologies' next earnings date?

Covalon Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, August 27th 2019. View Earnings Estimates for Covalon Technologies.

Has Covalon Technologies been receiving favorable news coverage?

Media headlines about COV stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Covalon Technologies earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Covalon Technologies.

Who are some of Covalon Technologies' key competitors?

What other stocks do shareholders of Covalon Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Covalon Technologies investors own include Kinaxis (KXS), Photon Control (PHO), Square (SQ), Aurora Cannabis (ACB), Enbridge (ENB), National Bank of Canada (NA), Shopify (SHOP), Toronto-Dominion Bank (TD), Namaste Technologies (N) and Reliq Health Technologies (RHT).

Who are Covalon Technologies' key executives?

Covalon Technologies' management team includes the folowing people:
  • Mr. Brian E. Pedlar, Pres, CEO & Director
  • Dr. Valerio DiTizio, Co-Founder, Chief Scientific Officer & VP (Age 51)
  • Mr. Danny Brannagan, Chief Financial Officer
  • Simon Smith, Chief Exec. Officer of Covalon Technologies Europe
  • Mr. Hamed Abbasian, VP of Bus. Devel.

How do I buy shares of Covalon Technologies?

Shares of COV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Covalon Technologies' stock price today?

One share of COV stock can currently be purchased for approximately C$4.15.

How big of a company is Covalon Technologies?

Covalon Technologies has a market capitalization of C$92.29 million and generates C$35.17 million in revenue each year. View Additional Information About Covalon Technologies.

What is Covalon Technologies' official website?

The official website for Covalon Technologies is http://www.covalon.com/.

How can I contact Covalon Technologies?

Covalon Technologies' mailing address is 1660 Tech Ave Unit 5, MISSISSAUGA, ON L4W 5S7, Canada. The company can be reached via phone at +1-905-5688400.


MarketBeat Community Rating for Covalon Technologies (CVE COV)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  64 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  117
MarketBeat's community ratings are surveys of what our community members think about Covalon Technologies and other stocks. Vote "Outperform" if you believe COV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/20/2019 by MarketBeat.com Staff

Featured Article: Quiet Period Expirations

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel